Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-06
1993-04-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514326, 514343, 514444, 514475, 549 60, 549332, 548517, 546226, 546282, 544147, 544374, A61K 31535, A61K 31335, C07D41314, C07D30302
Patent
active
052043452
ABSTRACT:
The present invention relates to a compound of the formula: ##STR1## wherein R.sup.1 is 2-methyl-1-propenyl group or isobutyl group; R.sup.2 is hydrogen atom, an optionally substituted aliphatic hydrocarbon residue or an optionally substituted acyl group, or a salt thereof.
The compound (I) of the invention has, among others, angiogenesis inhibiting activity, cell-proliferation inhibiting activity and immune reaction inhibiting activity, thus being useful as medicines, etc.
REFERENCES:
Corey et al. "Total Synthesis of (.+-.) Fumagillin" CA 76 153444s (1972).
Tarbell et al. II "The Chemistry of Fumagillin" CA 56 2401f (1962).
Belgian Patents Repnt. No. 42/69 col. 1 formula No. II-IV and #731495.
Chemical Patent Index, Basic Abstracts Journal Section B, Week 8706, Abstract No. 87-040948/06, Abstract of JP-A-476/1987.
J. A. DiPaolo, et al., Antibiotics Annual 1958-1959, pp. 541-546.
Journal of American Chem. Society, vol. 83, pp. 3096-3113 (1961).
The Journal of Antibiotics, vol. 41, pp. 999-1008 (1988).
Fujita Takeshi
Kishimoto Shoji
Conlin David G.
Ivy C. Warren
Owens A. A.
Resnick David S.
Takeda Chemical Industries Ltd.
LandOfFree
6-epifumagillols and the pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-epifumagillols and the pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-epifumagillols and the pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526278